Stock listing

SCYX Stock Price, News, Filings & Events — Scynexis, Inc.

Selected listing: SCYX · BOATS · USD · US

This page tracks Scynexis, Inc.'s SCYX:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following SCYX:BOATS. SCYX:BOATS is the stock-level entry point for investors researching Scynexis, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Scynexis, Inc. is a public company traded under the ticker SCYX in the American market. The company has a market capitalization of approximately $37 million. Scynexis focuses on developing innovative therapies for serious infections, particularly in the area of antifungal treatments.

SCYX:BOATSUSDUSUpdated August 31, 2026
Scynexis, Inc. logo
Ticker
SCYX:BOATS
Asset type
Stock
Market cap
$53.6M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
BOATS
Currency
USD

Scynexis, Inc. SCYX:BOATS stock context

This page tracks Scynexis, Inc.'s SCYX:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following SCYX:BOATS. SCYX:BOATS is the stock-level entry point for investors researching Scynexis, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Scynexis, Inc. is a public company traded under the ticker SCYX in the American market. The company has a market capitalization of approximately $37 million. Scynexis focuses on developing innovative therapies for serious infections, particularly in the area of antifungal treatments.

Latest news from Scynexis, Inc.

All Scynexis, Inc. news →

Scynexis, Inc. earnings calls

Research Scynexis, Inc.

Alternate listings